MedTrace Logo

Phenylephrine Infusion in Cesarean Delivery

NCT03248817 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2019-11-25

No results posted yet for this study

Summary

the investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine

Conditions

  • Cesarean Section Complications
  • Spinal Anesthesia

Interventions

DRUG

single shot phenylephrine

a single shot of phenylephrine (1.5 mcg/Kg) will be administrated intravenously

DRUG

fixed infusion phenylephrine

fixed infusion of phenylephrine will be administrated at a rate of 0.75 mcg/Kg/min.

DRUG

variable infusion phenylephrine

Variable infusion of phenylephrine will be administrated at a starting rate of 0.75 mcg/Kg/min.

DRUG

Bupivacaine

Bupivacaine will be administrated in the subarachnoid space for spinal anesthesia

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Mukhtar, Professor · Head of research committee section in anesthesia department

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-28
Primary Completion
2020-05-15
Completion
2020-05-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248817 on ClinicalTrials.gov